We are monitoring the impact of COVID-19 on Latin America Renal Disease Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1221
Share on
Share on

Latin America Renal Disease Therapeutics Market Research Report – Segmented By Application, Treatment Devices & Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1221
Pages: 145

The size of the Latin America Renal Disease Therapeutics Market is estimated to grow at a steady CAGR between 2021 to 2026.

Because of the high incidence of Diabetic cases and loss of accurate functioning of the deposition of some antibodies like IgA in the glomerulus, administration of analgesics, long-term exposure to lead or its salts, toxicity of chemotherapy agents leads to renal diseases. Kidneys have a number of functions, such as maintaining the balance of minerals such as sodium and potassium in the blood and water, remove waste products from the blood after digestion, and exposure to chemicals or medications. If any form of damage to kidney occurs, they ultimately lose their vital function, which is fatal.

Growing aging population, increasing number of individuals with insurance due to the Affordable Care Act, Increasing Diabetic Population, growing awareness of both acute and chronic kidney disease, and growing demand for the advanced diagnostics and therapeutics for the disease are the major factors that are driving the growth of Latin America Renal disease Therapeutics Market. The factors that are hindering the growth of the market are disparities of Renal Transplant Therapy, expiring of patents of some of the branded drugs for the late stage CKD and changing reimbursement scenario in some of major countries, Negative Societal Effects.

The Latin America Renal Disease Therapeutics market is segmented based on the Application, and treatment. Application mode is segmented into Kidney Stone Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Kidney Disease, Hypertension, Diabetes, and Anaemia. The treatment segment is further categorized into Dialysis Equipment, Renal Denervation devices, Wearable artificial kidney device, and distal embolic protection devices. On the basis of geography, the Latin America Renal Disease Therapeutics market is analysed under various regions namely Brazil, Argentina, and Mexico.

Some of the key players operating in Latin America Renal disease therapeutics market are Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International, Davita Healthcare Partners.


                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Kidney Stone Disease         

                                5.1.3 End-Stage Kidney Disease

                                5.1.4 Kidney Failure        

                                5.1.5 Chronic Kidney Disease     

                                5.1.6 Hypertension        

                                5.1.7 Diabetes  

                                5.1.8 Anaemia  

                                5.1.4 Y-o-Y Growth Analysis, By Application         

                                5.1.5 Market Attractiveness Analysis, By Application        

                                5.1.6 Market Share Analysis, By Application         

                5.2 Treatment devices                  

                                5.2.1 Introduction           

                                5.2.2 Dialysis Equipment              

                                5.2.3 Renal Denervation devices

                                5.2.4 Wearable artificial kidney device   

                                5.2.5 distal embolic protection devices  

                                5.2.6 Y-o-Y Growth Analysis, By Treatment devices           

                                5.2.7 Market Attractiveness Analysis, By Treatment devices         

                                5.2.8 Market Share Analysis, By Treatment devices          

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Application

                                       By Treatment Devices

                                6.1.4 Market Attractiveness Analysis      

                                       By Geographical Area

                                       By Application

                                       By Treatment devices

                                6.1.5 Market Share Analysis        

                                       By Geographical Area

                                       By Application

                                       By Treatmentr Devices

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Amgen Inc.                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck & Co., Inc.                     

                8.3 Bristol-Myers Squibb Company                          

                8.4 Hoffmann-La Roche Inc                         

                8.5 Shire Inc.                     

                8.6 Fresenius Medical Care                         

                8.7 Baxter International               

                8.8 Davita Healthcare Partners                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Avail of sample brochure of the report to get access to the list of figures and tables of the report. 

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample